克服瘤排水淋巴结中的抗原呈现受损,有助于免疫治疗
Meghan J O'Melia1, Lutz Menzel1, Pin-Ji Lei1
1Department of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
bioRxiv : the preprint server for biology
|September 26, 2025
概括
乳腺瘤通过减少淋巴结中的IL1β来损害T细胞反应,阻碍抗原呈现. 针对遥远的淋巴结或恢复IL1β可以克服这一问题,改善免疫治疗的疗效和存活率.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫疗法已经改变了癌症治疗,但由于针对有限的免疫反应步骤,往往会失败.
- 抗原的处理和呈现对于抗癌免疫是至关重要的,但大多数当前的免疫疗法并没有针对它们.
研究的目的:
- 研究乳腺瘤如何影响地方区域抗原呈现和T细胞反应.
- 确定克服瘤诱导免疫抑制和增强免疫治疗有效性的策略.
主要方法:
- 评估了瘤排水和遥远淋巴结中的抗原呈现和T细胞反应.
- 研究了IL1β在瘤介导免疫抑制中的作用.
- 评估了向遥远的淋巴结输送辅助剂和IL1β恢复以增强抗瘤免疫力.
主要成果:
- 乳腺瘤通过降低IL1β水平,损害了局域性淋巴结抗原的呈现,但不能进行处理.
- 向遥远的淋巴结输送抗原无定性辅助剂改善了抗瘤T细胞的反应.
- 恢复IL1β或用辅助剂向遥远的淋巴结,结合免疫检查点阻塞,导致长期存活和防止复发.
结论:
- 淋巴结中抗原呈现的瘤诱导损伤可以通过战略辅助剂或IL1β恢复来克服.
- 这些方法可以产生持久的抗癌免疫反应,并对改善免疫治疗结果具有重大临床影响.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.7K
相关概念视频
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
01:40Cell-mediated Immune Responses
83.5K
Overview
83.5K